Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI …
…, M Krutikov, T Palmer, R Giddings, B Azmi… - The Lancet Infectious …, 2021 - thelancet.com
Background The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-…
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-…
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic …
Background Long-term care facilities (LTCFs) have reported high SARS-CoV-2 infection
rates and related mortality, but the proportion of infected people among those who have …
rates and related mortality, but the proportion of infected people among those who have …
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
M Krutikov, O Stirrup, H Nacer-Laidi, B Azmi… - The Lancet Healthy …, 2022 - thelancet.com
Background The SARS-CoV-2 omicron variant (B.1.1.529) is highly transmissible, but disease
severity appears to be reduced compared with previous variants such as alpha and delta. …
severity appears to be reduced compared with previous variants such as alpha and delta. …
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes …
Background Residents of long-term care facilities (LTCFs) have been prioritised for COVID-19
vaccination because of the high COVID-19 mortality in this population. Several countries …
vaccination because of the high COVID-19 mortality in this population. Several countries …
Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a …
M Shrotri, M Krutikov, H Nacer-Laidi, B Azmi… - The Lancet Healthy …, 2022 - thelancet.com
Background Residents and staff in long-term care facilities have been prioritised for vaccination
against SARS-CoV-2, but data on potential waning of vaccine effectiveness and the …
against SARS-CoV-2, but data on potential waning of vaccine effectiveness and the …
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort …
…, M Krutikov, R Giddings, M Shrotri, B Azmi… - The Lancet Healthy …, 2022 - thelancet.com
Background Older age and frailty are risk factors for poor clinical outcomes following SARS-CoV-2
infection. As such, COVID-19 vaccination has been prioritised for individuals with …
infection. As such, COVID-19 vaccination has been prioritised for individuals with …
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
Third-dose coronavirus disease 2019 vaccines are being deployed widely but their efficacy
has not been assessed adequately in vulnerable older people who exhibit suboptimal …
has not been assessed adequately in vulnerable older people who exhibit suboptimal …
Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study …
…, M Krutikov, H Nacer-Laidi, B Azmi… - Open Forum …, 2023 - academic.oup.com
Background Successive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants have caused severe disease in long-term care facility (LTCF) residents. Primary …
variants have caused severe disease in long-term care facility (LTCF) residents. Primary …
[HTML][HTML] Built environment and SARS-CoV-2 transmission in Long-term care facilities: cross-sectional survey and data linkage
M Krutikov, O Stirrup, C Fuller, N Adams, B Azmi… - Journal of the American …, 2024 - Elsevier
Objectives To describe the built environment in long-term care facilities (LTCF) and its
association with introduction and transmission of SARS-CoV-2 infection. Design Cross-sectional …
association with introduction and transmission of SARS-CoV-2 infection. Design Cross-sectional …
Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of long-term care facilities in the VIVALDI study
…, M Shrotri, NL Adams, M Krutikov, B Azmi… - Age and …, 2023 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused severe
disease in unvaccinated long-term care facility (LTCF) residents. Initial booster vaccination …
disease in unvaccinated long-term care facility (LTCF) residents. Initial booster vaccination …